Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 81: 761-773, 1996;
8750-7587/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunga, H. C.
Right arrow Articles by Rocker, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunga, H. C.
Right arrow Articles by Rocker, L.

Journal of Applied Physiology, Vol 81, Issue 2 761-773, Copyright © 1996 by American Physiological Society

ARTICLES

Erythropoietin under real and simulated microgravity conditions in humans

H. C. Gunga, K. Kirsch, F. Baartz, A. Maillet, C. Gharib, W. Nalishiti, I. Rich and L. Rocker
Department of Physiology, Free University of Berlin, Germany.

The aim of this study was to analyze the time course of erythropoietin (EPO) during Earth-bound microgravity simulations such as bed rest, isolation and confinement (IC), head-down tilt (HDT; -6 degrees), and immersion to evaluate which factors could contribute to alterations in EPO under real microgravity conditions during and after short- (< 10 days) and long-term (> 6 mo) spaceflights. During bed rest (24h), no significant changes in EPO could be observed. Subjects confined in a diving chamber facility for 60 days showed a decrease in EPO. In the recovery period a slight increase was observed, but EPO concentrations did not reach the pre-IC control level. In the control period before HDT, subjects showed normal resting values for EPO, but on day 2 of HDT the EPO concentrations were decreased (P < 0.01). Later the EPO levels remained below the control value and were increased after HDT (P < 0.05). After immersion (24 h) increased EPO concentrations could be determined (P < 0.05). During a short-term spaceflight the astronauts showed in-flight (day 4) decreased and unchanged EPO concentrations. During a long-term spaceflight, 24 h after recovery, the cosmonaut showed slightly elevated EPO concentration, which increased markedly during the following days. It is concluded that 1) HDT (-6 degrees) causes a rapid decrease in EPO in humans, 2) IC per se leads to diminished EPO concentrations, 3) EPO regulation in humans during short- and long-term spaceflights might be different, 4) changes in central blood volume, i.e., central venous pressure, seem to be involved in the modulation of EPO production and release under simulated and real microgravity conditions, and 5) the HDT (-6 degrees) Earth-bound simulation reflects mostly the changes in EPO production and release observed under real microgravity conditions in humans.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
A. Chouker, L. Smith, F. Christ, I. Larina, I. Nichiporuk, V. Baranov, E. Bobrovnik, L. Pastushkova, K. Messmer, K. Peter, et al.
Effects of confinement (110 and 240 days) on neuroendocrine stress response and changes of immune cells in men
J Appl Physiol, April 1, 2002; 92(4): 1619 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Chouker, M. Thiel, V. Baranov, D. Meshkov, A. Kotov, K. Peter, K. Messmer, and F. Christ
Simulated microgravity, psychic stress, and immune cells in men: observations during 120-day 6{degrees} HDT
J Appl Physiol, May 1, 2001; 90(5): 1736 - 1743.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online